PT975327E - Uso de antagonistas de 5ht3 para estimular a lavagem intestinal - Google Patents

Uso de antagonistas de 5ht3 para estimular a lavagem intestinal

Info

Publication number
PT975327E
PT975327E PT98922759T PT98922759T PT975327E PT 975327 E PT975327 E PT 975327E PT 98922759 T PT98922759 T PT 98922759T PT 98922759 T PT98922759 T PT 98922759T PT 975327 E PT975327 E PT 975327E
Authority
PT
Portugal
Prior art keywords
antagonists
stimulate intestinal
intestinal washing
washing
stimulate
Prior art date
Application number
PT98922759T
Other languages
English (en)
Inventor
Antonius Adrianus Hendr Megens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT975327E publication Critical patent/PT975327E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT98922759T 1997-04-18 1998-04-14 Uso de antagonistas de 5ht3 para estimular a lavagem intestinal PT975327E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201149 1997-04-18

Publications (1)

Publication Number Publication Date
PT975327E true PT975327E (pt) 2003-11-28

Family

ID=8228223

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98922759T PT975327E (pt) 1997-04-18 1998-04-14 Uso de antagonistas de 5ht3 para estimular a lavagem intestinal

Country Status (12)

Country Link
US (2) US6235745B1 (pt)
EP (1) EP0975327B1 (pt)
JP (1) JP2001523239A (pt)
KR (1) KR100529512B1 (pt)
AT (1) ATE243993T1 (pt)
AU (1) AU745361B2 (pt)
CA (1) CA2286076C (pt)
DE (1) DE69816060T2 (pt)
DK (1) DK0975327T3 (pt)
ES (1) ES2202855T3 (pt)
PT (1) PT975327E (pt)
WO (1) WO1998047481A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090638A1 (en) * 1999-10-08 2001-04-11 Sanofi-Synthelabo Use of (R)-zacopride or a salt thereof for the manufacture of a medicament for the treatment of sleep apnea
AU2002231627A1 (en) * 2000-11-24 2002-06-03 Janssen Pharmaceutica N.V. Use of a triple combination comprising a 5HT3 antagonist, a 5HT4 agonist and a laxative for promoting intestinal lavage
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
TWI332943B (en) * 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
US6946149B2 (en) * 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
AU2003272740A1 (en) * 2002-10-01 2004-04-23 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 4,6-diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors
US6996500B2 (en) * 2002-10-30 2006-02-07 Hewlett-Packard Development Company, L.P. Method for communicating diagnostic data
WO2004062623A2 (en) * 2003-01-13 2004-07-29 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
DE602004005814T2 (de) * 2003-01-13 2008-01-10 Dynogen Pharmaceuticals Inc., Waltham Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
EP1539181B1 (en) * 2003-04-04 2007-06-27 Dynogen Pharmaceuticals Inc. Method of treating lower urinary tract disorders
US7049319B2 (en) * 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
US20070155780A1 (en) * 2004-04-15 2007-07-05 Hitoshi Nakata Stabilized composition containing 4-amino-5-chloro-n-[(1r, 3r, 5s)-8-methyl-8-azabicyclo[3.2.1]oct-3-y1]-2-[1-methylbut-2-ynyloxy]benzamide
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
WO2007019888A2 (en) * 2005-08-12 2007-02-22 Ctg Pharma S.R.L. Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases
US7678832B2 (en) * 2005-08-16 2010-03-16 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) formulation
EP2275095A3 (en) * 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
US7553846B2 (en) 2006-08-07 2009-06-30 Albany Molecular Research, Inc. 2-alkylbenzoxazole carboxamides as 5-HT3 modulators
RU2448105C2 (ru) * 2006-08-07 2012-04-20 Олбани Молекьюлар Рисерч, Инк. 2-аминобензоксазолкарбоксамиды в качестве модуляторов 5-нт3
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
ES2764462T3 (es) 2013-03-15 2020-06-03 Braintree Laboratories Inc Comprimidos de composición farmacéutica oral de uso dual de sales de sulfato y métodos de uso de los mismos
US10172833B2 (en) 2015-08-11 2019-01-08 Insys Development Company, Inc. Sublingual ondansetron spray
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
EP3858828A4 (en) * 2018-09-28 2022-07-06 Takeda Pharmaceutical Company Limited HETEROCYCLIC COMPOUND

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB893267A (en) 1958-11-25 1962-04-04 Sterling Drug Inc Laxative enemas
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
TW294595B (pt) 1992-11-20 1997-01-01 Janssen Pharmaceutica Nv
US6103734A (en) 1994-11-04 2000-08-15 Legarda Ibanez; Juan Jose Drug combination as a medicament to suppress the dependence of individuals to opiates
WO1996014071A1 (es) 1994-11-04 1996-05-17 Legarda Ibanez Juan Jose Combinacion de farmacos como medicamento destinado a supresion de dependencia de individuos a opiaceos
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
CA2286076C (en) 2006-12-12
KR20000075858A (ko) 2000-12-26
AU745361B2 (en) 2002-03-21
US6235745B1 (en) 2001-05-22
JP2001523239A (ja) 2001-11-20
US6555546B2 (en) 2003-04-29
EP0975327B1 (en) 2003-07-02
KR100529512B1 (ko) 2005-11-22
WO1998047481A1 (en) 1998-10-29
DE69816060T2 (de) 2004-04-22
DE69816060D1 (de) 2003-08-07
DK0975327T3 (da) 2003-10-20
ATE243993T1 (de) 2003-07-15
AU7528298A (en) 1998-11-13
ES2202855T3 (es) 2004-04-01
EP0975327A1 (en) 2000-02-02
US20010020025A1 (en) 2001-09-06
CA2286076A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
PT975327E (pt) Uso de antagonistas de 5ht3 para estimular a lavagem intestinal
TR200000782T2 (tr) Resorsinol türevleri.
DK0880523T3 (da) Pyrazolopyrimidiner som CRF-receptorantagonister
ES2184797T3 (es) Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia.
DE69819311D1 (de) Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
UY27079A1 (es) Procedimiento para la preparación de un anticolinérgico
BR9909486A (pt) Compostos calcilìticos
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
DE69804198D1 (de) Zementschlamm für die zementierung von bohrlöchern insbesondere ölbohrlöchern
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
TR200102742T2 (tr) Rezorsinol türevleri
EA200100854A1 (ru) Кальций-литические соединения
BR9807888B1 (pt) sabÕes lÍquidos, bem como uso de triclocarbano.
NO913919L (no) Vandig, tiksotropisk vaskemiddelblanding.
AR005704A1 (es) Heteroariloxazolidinonas
NO20000434D0 (no) Lyksofuranosyl benzimidazoler som antivirale midler
DE69727452D1 (de) Faltenbalgartiger, zylindrischer Körper
AR021616A1 (es) Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos.
ES2178111T3 (es) Uso de un compuesto 2-aroil-3-arilbenzo(b)tiofeno para rebajar los niveles de fibrinogeno.
KR980004002U (ko) 내부 조직상태를 확인할수 있도록 한 p.v.c 호스
AR023389A1 (es) Nuevo uso
ES2180926T3 (es) Procedimiento para la preparacion de 2-halometil-penem y su uso en la preparacion de penem antibacterianos.
ES2056995T3 (es) Anticuerpo monoclonal anti-cpbii.
BR9603438A (pt) Mistura para atomização reforçada com fibra
KR960005287U (ko) 건축, 토목용 비계 설치구